The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review

Background Generic drugs are considered therapeutically equivalent to their original counterparts and lower in acquisition costs. However, the overall impact of generic substitution (GS) on global clinical and economic outcomes has not been conclusively evaluated.